Clinical Trial Update: Interferon Alfa With or Without Combination Chemotherapy Plus Interleukin-2 in Treating Patients With Melanoma [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating interferon alfa-2b with or without combination chemotherapy plus interleukin-2 for melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Interferon alfa-2b (interferon alfa-2b)
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Melanoma, Skin Cancer | Phase 3 | Status: COMPLETED